| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/26/1997 | CN1143963A Tetracyclic derivatives, process of preparation and use |
| 02/26/1997 | CN1143956A 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, process for preparing same and their use as medicaments |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605923 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor |
| 02/25/1997 | US5605825 Human PAK65 |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites |
| 02/25/1997 | CA1338939C Vinylphenol derivatives, their preparation and their use |
| 02/25/1997 | CA1338937C Process for the manufacture of novel substituted alkanediphosphonic acids |
| 02/20/1997 | WO1997006260A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/20/1997 | WO1997005895A1 Treatment of ocular inflammatory conditions with interleukin-10 |
| 02/20/1997 | WO1997005894A1 Pharmaceutical composition containing il-10 |
| 02/20/1997 | WO1997005878A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005877A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005862A2 Use of basic amino acids and derivatives for lowering ceramide levels |
| 02/20/1997 | WO1996040260A3 Immunotoxins specific for cd80 and cd86 expressing cells |
| 02/20/1997 | CA2228620A1 Treatment of ocular inflammatory conditions with interleukin-10 |
| 02/20/1997 | CA2228136A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | CA2228050A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | CA2201282A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/19/1997 | EP0758656A2 Immunoglobulin activated by mixing with a histamine component |
| 02/19/1997 | EP0758650A1 Endothelin receptor antagonists |
| 02/19/1997 | EP0758452A1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 02/19/1997 | EP0758393A1 Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils |
| 02/19/1997 | EP0758390A1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/19/1997 | EP0758329A1 Morpholine derivatives and their use as antagonists of tachikinins |
| 02/19/1997 | EP0758328A1 Anti-cancer compounds containing cyclopentaquinazoline ring |
| 02/19/1997 | EP0758312A1 Substituted fused and bridged bicyclic compounds as therapeutic agents |
| 02/19/1997 | EP0758247A1 O-desulfated heparin derivatives, methods of making and uses thereof |
| 02/19/1997 | EP0758243A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa |
| 02/19/1997 | EP0758238A1 Spiro-substituted azacycles as neurokinin-3 antagonists |
| 02/19/1997 | EP0654026B1 Isoserine derivatives and their use as leukotriene antagonists |
| 02/19/1997 | CN1143366A 4-amino derivatives of mycophenolic acid |
| 02/19/1997 | CN1143365A Phenyl-heterocycles as COX-2 inhibitors |
| 02/19/1997 | CN1143363A Isoxazoline compounds as inhibitors of TNF release |
| 02/19/1997 | CN1143319A Compound and methods for treatment of cardiovascular, inflammatory and immune disorders |
| 02/19/1997 | CN1142966A Making up method for medicinal liquid of ice guide therapeutic method on channels and acupuncture point |
| 02/19/1997 | CN1034055C Monoclone antibody used for preparing medicine of therapeutic imflammation region |
| 02/18/1997 | US5604260 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
| 02/18/1997 | US5604252 Substance p antagonist |
| 02/18/1997 | US5604247 Chromone Derivatives |
| 02/18/1997 | US5604231 Non-steroidal antiinflammatory agents, dopaminergic agents; side effect reduction |
| 02/18/1997 | US5604216 Diluted mixtures for use as drugs or nutritional supplements |
| 02/18/1997 | US5604207 Sialyl Lex analogues as inhibitors of cellular adhesion |
| 02/18/1997 | US5604206 Complexes containing S(+) phenyl alkane acids and amino sugars |
| 02/18/1997 | US5603959 Non-steroidal anti-inflammatory drug linked with unsaturated fatty acid or alcohol; cytoprotective agents, side effect reduction |
| 02/18/1997 | US5603957 Microcapsules for the controlled release of acetylsalicyclic acid in the gastrointestinal environment |
| 02/18/1997 | US5603951 Cyclosporin-containing soft capsule compositions |
| 02/18/1997 | US5603943 Physiologically active substance homogeneously dispersed in and adsorbed on polyvalent metal carrier of specified particle size |
| 02/17/1997 | CA2183307A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997005285A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005244A1 Mocarhagin, a cobra venom protease, and therapeutic uses thereof |
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | WO1997005105A1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 02/13/1997 | WO1997004807A1 Methods for treatment of allergic asthma |
| 02/13/1997 | WO1997004792A1 Bowman-birk inhibitor compositions for treatment of imflammatory disease |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004768A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | WO1997004765A1 INHIBITION OF CoA-INDEPENDENT TRANSACYLASE AND APOPTOSIS |
| 02/13/1997 | WO1996035774A3 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/13/1997 | CA2228298A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | CA2227972A1 Mocarhagin, a cobra venom protease and therapeutic uses thereof |
| 02/13/1997 | CA2227769A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | CA2226624A1 Methods for treatment of allergic asthma |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/13/1997 | CA2223968A1 Bowman-birk inhibitor compositions for treatment of inflammatory disease |
| 02/12/1997 | EP0757719A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY |
| 02/12/1997 | EP0757716A1 Dna encoding bradykinin b 1? receptor |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142832A CS-1 peptidomimetics, compositions and methods of using the same |
| 02/12/1997 | CN1142819A Morpholine and thiomorpholine tachykinin receptor antagonists |
| 02/12/1997 | CN1142817A 1N-alkyl-N-arylpyrimidinamines and derivatives thereof |
| 02/12/1997 | CN1142499A Tricyclic 5,6-dihydro-9H-pyrazolo|3,4-c¨-1,2,4,-triaolo (4,3-alpha¨ pyridines |
| 02/12/1997 | CN1142496A New thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/12/1997 | CN1142493A Arylalkylpyridzinones |
| 02/12/1997 | CN1034016C Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids |
| 02/12/1997 | CA2183020A1 Activated immunoglobulin |
| 02/11/1997 | US5602253 Peptides derivatives |
| 02/11/1997 | US5602230 Peptide inhibitors of selectin binding |
| 02/11/1997 | US5602173 Inhibit phosphodiesterase activity, tumor necrosis factor production |
| 02/11/1997 | US5602157 Compounds useful for treating allergic and inflammatory diseases |
| 02/11/1997 | US5602154 Administering an enzyme inhibitor treating degenerative diseases |
| 02/11/1997 | US5602138 Neurokinin a antagonists; treating asthma |
| 02/11/1997 | US5602115 Bisphosphonic acid derivatives as anti-arthritic agents |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5601842 Analgesics; contains a non-moisture sensitive matrixing agent |
| 02/11/1997 | CA2034546C 1, 3-dicarbonyl compounds and their use |
| 02/06/1997 | WO1997003984A1 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] |
| 02/06/1997 | WO1997003953A1 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclo-oxygenase ii |
| 02/06/1997 | WO1997003951A1 Esters and amides as pla2 inhibitors |
| 02/06/1997 | WO1997003783A1 Metalloproteinase inhibitors |
| 02/06/1997 | WO1997003699A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | WO1997003686A1 Tnf receptor and steroid hormone in a combined therapy |
| 02/06/1997 | WO1997003678A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/06/1997 | WO1997003670A1 Paroxetine controlled release compositions |